Contact    |    Sitemap    

Email Signup  |  Share |

Board of Directors

  • Michael Borofsky – Director – Senior Vice President, MacAndrews & Forbes
  • Richard Geoffrion – Director – CEO, Mitralign
  • Avi Molcho – Director – Venture Partner, Forbion Capital Partners
  • Alexia Perouse – Director – Biotech Partner, Crédit Agricole Private Equity
  • Eric Rose, MD – Director – Executive Vice President, MacAndrews & Forbes
  • Paul Southworth – Director – President and CEO, CircuLite, Inc.
  • Martien van Osch – Director – Managing Partner, Forbion Capital Partners
  • Terry Vance – Director – Venture Partner, Saints Capital
  • Lee Wrubel, MD – Director – General Partner, Foundation Medical Partners

 

 

 

 

 

Mr. Michael Borofsky, Senior Vice President of MacAndrews & Forbes. Prior to joining MacAndrews & Forbes in 2003, Mr. Borofsky was with the law firm of Skadden, Arps, Slate, Meagher & Flom LLP, where he specialized in mergers & acquisitions, and was an analyst in the treasury group of Goldman Sachs Group, Inc.

 

For additional information on Mr. Borofsky click here.

 

 

Mr. Rick Geoffrion, CEO, Mitralign, Tewksbury, MA, possesses over 20 years of management and investment experience in the medical device industry.

 

For additional information on Mr. Geoffrion click here.

 

 

Mr. Avi Molcho, Venture Partner, joined Forbion Capital Partners in early 2007 mainly on medical technologies opportunities.

 

For additional information on Mr. Molcho click here.

 

 

Ms. Alexia Perouse, Biotech Partner, joined Crédit Agricole Private Equity in 2005 and possesses over 10 years of investment experience in Life Sciences.

 

For additional information on Ms. Perouse click here.

 

 

Mr. Paul Southworth, President and CEO, CircuLite, Inc., joined CircuLite in 2004 with over 30 years experience in the medical device industry.

 

For additional information on Mr. Southworth click here.

 

 

Dr. Eric Rose, Executive Vice President of MacAndrews & Forbes, is an academic physician and entrepreneur with interests in drug discovery, biodefense, clinical evaluative research and health policy.

 

For additional information on Dr. Rose click here.

 

 

Mr. Martien van Osch, Managing Partner, Forbion Capital Partners (formerly ABN AMRO Capital Life Sciences), joined ABN AMRO in 1996 and possess over 15 years of investment experience with a focus on medical devices.

 

For additional information on Mr. van Osch click here.

 

 

Mr. Terry Vance, Venture Partner, has worked with Saints Capital since 2011 and has been in the venture investment business for ten years, following a career and as a banker and consultant to emerging companies.

 

For additional information on Mr. Vance click here.

 

 

Dr. Lee Wrubel, General Partner, Foundation Medical Partners, has over 10 years experience in the field of equity investment and has been associated with a large number of privates companies and now public companies.

 

For additional information on Dr. Wrubel click here.